140 results
8-K
EX-10.1
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
a Material Adverse Effect. There is no pending, completed or, to the Company’s knowledge, threatened, action (including any lawsuit, arbitration, or legal
424B5
SEEL
Seelos Therapeutics Inc
20 May 24
Prospectus supplement for primary offering
4:16pm
good and substantial defenses to the claims alleged by Empery, but there is no guarantee that Empery will not bring a lawsuit against us or that we
8-K
EX-10.1
SEEL
Seelos Therapeutics Inc
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative
424B5
zpa2xfju ecruh
30 Jan 24
Prospectus supplement for primary offering
6:05am
424B5
o0a2em57bm r6qt
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
umi22u 87mz78
28 Nov 23
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
ren4o1i0
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-10.1
btwgt9w 3c
10 Jan 22
Departure of Directors or Certain Officers
4:28pm